FRI415 Patient Preference And Proof-of-concept For A Once-daily Follicle Stimulating Hormone (FSH) Biosimilar Delivered Via An Orally Ingestible Robotic Pill (RT-112)

Disclosure: A. Yamaguchi: Employee; Self; Rani Therapeutics. Stock Owner; Self; Rani Therapeutics. K. Horlen: Employee; Self; Rani Therapeutics. Stock Owner; Self; Rani Therapeutics. N. Patel: Employee; Self; Rani Therapeutics. Stock Owner; Self; Rani Therapeutics. V. Tran: Employee; Self; Rani Ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaguchi, Alyson, Horlen, Kyle, Patel, Nidhi, Tran, Vinh, Vo, April T, Medida, Ramya Lekha, Myers, Joshua T, Fung, Leonard C, Kaminskaya, Kristina, Mohan, Deepa, Nguyen, Vy, Nguyen, Son, Syed, Baber, Dhalla, Arvinder K, Imran, Mir, Hashim, Mir A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Reproductive Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554912/
http://dx.doi.org/10.1210/jendso/bvad114.1608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554912/
http://dx.doi.org/10.1210/jendso/bvad114.1608

Ejemplares similares